Clinical Trials Directory

Trials / Unknown

UnknownNCT02158624

Ranibizumab Treatment for Age-Related Macular Degeneretion

The Correlation for Improvement of Visual Acuity and QOL After Ranibizmab Treatment for Age-Related Macular Degeneration Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Kyushu University · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

To establish the correlation between visual acuity improvement and QOL measurement after ranibizumab treatment for AMD patients.

Conditions

Interventions

TypeNameDescription
DRUGIntravitreal Lucentis 0.5mg

Timeline

Start date
2013-12-01
Primary completion
2015-04-01
Completion
2015-12-01
First posted
2014-06-09
Last updated
2014-06-09

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02158624. Inclusion in this directory is not an endorsement.

Ranibizumab Treatment for Age-Related Macular Degeneretion (NCT02158624) · Clinical Trials Directory